Silihan lan utang jangka dawa perusahaan Procaps Group SA (PROC)

Procaps Group SA - logo grafis emiten PROC

The price evolution of Procaps Group S.A. (PROC) demonstrates a period of internal restructuring and auditing, with a complete pivot away from mergers in favor of profit recovery. The business leverages its status as a global leader in softgel capsule production, possessing significant pricing power in Latin America. Revenues depend on the cost of polymers, gelatin, and outsourcing demand, while the indicator stands at 0.00, confirming strict adherence to GMP standards.

PROC Procaps Group S.A.: Utang jangka dawa perusahaan ing interval 04.07.2022 - 16.02.2025
Produk sing diprodhuksi Procaps

Long-term debts reflect the aggregate of obligations with a maturity exceeding one year, determining the financial stability of the capital structure. It is essential for investors to evaluate this parameter as an indicator of debt load and interest expense risk. By analyzing the long-term debt dynamics of a company, one can identify excessive leverage. For Procaps Group S.A. (PROC), this is critical, as the outsourcing of production and logistics reduces capital expenditures. Controlling borrowings ensures the preservation of liquidity when delegating operational processes.

Analisis perusahaan pesaing

haleon.com - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Kenvue (KVUE)|VRNA: Silihan lan utang jangka dawa perusahaan|MENS (Jyong Biotech Corp) - Utang jangka dawa perusahaan|Ligand Corp (LGND) - Kewajiban jangka dawa perusahaan|AMRX (Amneal Pharmaceuticals) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan perrigo.com (PRGO)|Alvotech SA (ALVO) - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan LQDA (Liquidia Corp)|GLPG: Utang jangka dawa perusahaan|ANIP - Utang jangka dawa|Kewajiban jangka dawa perusahaan MannKind Corporation MNKD|AMPH - Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan Pacira BioSciences, Inc. PCRX|ARS Pharmaceuticals Inc (SPRY) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan TBPH (Theravance)|Utang jangka dawa AQST|scPharmaceuticals Inc. (SCPH) - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan TECX (tectonictx.com)|Tonix Pharmaceuticals Holding Corp. (TNXP) - Utang jangka dawa perusahaan|SXT Pharmaceuticals - Kewajiban jangka dawa|Utang jangka dawa perusahaan Eupraxia Pharma (EPRX)|BHST: Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Utang jangka dawa|Utang jangka dawa perusahaan ENTX|Kewajiban jangka dawa perusahaan MindWalk Holdings, Inc.|Utang jangka dawa perusahaan ABVC|Utang jangka dawa perusahaan CPIX (Cumberland Corp)|Quantum BioPharma Ltd (QNTM) - Utang jangka dawa perusahaan|fibrogen.com - Kewajiban jangka dawa|Utang jangka dawa perusahaan TELO (Telomir Pharmaceuticals, Inc.)|Rani Therapeutics (RANI) - Gunggunge utang jangka dawa|Kewajiban jangka dawa perusahaan synergychc.com SNYR|Rallybio (RLYB) - Silihan lan utang jangka dawa perusahaan|Lexaria Bioscience Corp - Utang jangka dawa perusahaan|Tanggungan jangka dawa PULM|Pheton Holdings Ltd (PTHL) - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan APM (aptorumgroup.com)|LYRA: Utang jangka dawa perusahaan|IBO - Utang jangka dawa|TNF Pharma - Kewajiban jangka dawa perusahaan|YCBD: Utang jangka dawa perusahaan|Utang jangka dawa perusahaan PainReform (PRFX)|Kewajiban jangka dawa Altamira Therapeutics Ltd.|LIPO - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan OPTN|PIRS (Pieris Pharmaceuticals) - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa petrospharma.com PTPI|Kewajiban jangka dawa perusahaan QLI|Gunggunge utang jangka dawa Acelyrin Inc. SLRN|TFF Pharma - Utang jangka dawa perusahaan